An Organometallic Gold(I) Bis‐N‐Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells
Samuel M. Meier, Benjamin Neuditschko, Katja Zappe, Martin Schaier, Marlene C. Gerner, Klaus G. Schmetterer, Giorgia Del Favero, Riccardo Bonsignore, Margit Cichna‐Markl, Gunda Koellensperger, Angela Casini, Christopher Gerner
Abstract
Abstract The organometallic Au I bis‐N‐heterocyclic carbene complex [Au(9‐methylcaffeine‐8‐ylidene) 2 ] + ( AuTMX 2 ) was previously shown to selectively and potently stabilise telomeric DNA G‐quadruplex (G4) structures. This study sheds light on the molecular reactivity and mode of action of AuTMX 2 in the cellular context using mass spectrometry‐based methods, including shotgun proteomics in A2780 ovarian cancer cells. In contrast to other metal‐based anticancer agents, this organogold compound is less prone to form coordinative bonds with biological nucleophiles and is expected to exert its drug effects mainly by non‐covalent interactions. Global protein expression changes of treated cancer cells revealed a multimodal mode of action of AuTMX 2 by alterations in the nucleolus, telomeres, actin stress‐fibres and stress‐responses, which were further supported by pharmacological assays, fluorescence microscopy and cellular accumulation experiments. Proteomic data are available via ProteomeXchange with identifier PXD020560.